Gasparyan, Samvel B. http://orcid.org/0000-0002-4797-2208
Buenconsejo, Joan http://orcid.org/0000-0003-4514-2208
Kowalewski, Elaine K. http://orcid.org/0000-0002-7915-877X
Oscarsson, Jan http://orcid.org/0000-0002-4573-517X
Bengtsson, Olof F. http://orcid.org/0000-0003-1315-8176
Esterline, Russell
Koch, Gary G.
Berwanger, Otavio
Kosiborod, Mikhail N.
Funding for this research was provided by:
AstraZeneca
Article History
Received: 28 January 2022
Accepted: 19 May 2022
First Online: 14 June 2022
Declarations
:
: SBG, JO, OFB and RE are employees and stockholders of AstraZeneca. JB was an employee of AstraZeneca at the time the manuscript was being prepared and now is employed at Bristol-Myers-Squibb. EKK has nothing to declare. GGK is the Principal Investigator of a biostatistics grant from AstraZeneca. He is also the Principal Investigator for biostatistics grants from other biopharmaceutical sponsors that have no relationship to the submitted work. OB has received research Grants from AstraZeneca, Pfizer, Servier, Novartis, Amgen, Bayer, and Boheringer-Ingelheim. MNK has received a research grant for the conduct of this study from AstraZeneca. He has also received Grant and research support from AstraZeneca. He has received a Grant and honoraria from Boehringer-Ingelheim, and honoraria from AstraZeneca, Alnylam, Amgen, Bayer, Eli Lilly, Esperion, Merck (Diabetes and Cardiovascular), Janssen, Novo Nordisk, Pharmacosmos and Vifor Pharma.
Free to read: This content has been made available to all.